SciClone Pharmaceuticals has named Dr. Friedhelm Blobel as president, CEO and a director of the company.

GammaCan International has appointed Patrick N.J. Schnegelsberg to the post of CEO. Vered Caplan will remain CEO of the company's Israeli subsidiary. 

Eksigent Technologies announced that David Weber has joined the company as CEO, president and director.

Affymetrix President Susan Siegel has resigned, but will stay on as president emeritus and company adviser. Thane Kreiner was named senior vice president of sales and marketing.

Antisoma has appointed Dr. Gary Acton as chief medical officer.

MGI PHARMA has appointed William F. Spengler as senior vice president and CFO.

WEX Pharmaceuticals has named Bill Chen CFO.

Endo Pharmaceuticals Holdings says financial chief Jeffrey R. Black will retire in August.

Javelin Pharmaceuticals has named Stephen Tulipano, CPA, as its CFO.

CytoCore has hired Dr. George Gorodeski as lead research scientist as well as head of the company's medical advisory board.

Clarence Young, M.D. has joined Protez Pharmaceuticals as its chief medical officer.

PTC Therapeutics has promoted Claudia Hirawat to senior vice president of corporate development.

NPS Pharmaceuticals has appointed Juergen Lasowski, Ph.D., as senior vice president of corporate development.

Praecis Pharmaceuticals has named O. Prem Das, Ph.D., as senior vice president, technology partnerships.

ZymoGenetics has hired Michael J. Dwyer as senior vice president of marketing and sales and as a member of the executive management committee.

Resverlogix Corp has named Dr. Gregory S. Wagner vice president of preclinical development.

Orthovita has hired Christine J. Arasin as vice president business development and corporate counsel.

FibroGen has named Tim C. Opler as vice president of strategy.

BrainStorm Cell Therapeutics has engaged Dr. Holly G. Atkinson as the company's contract director of business development.

Dr. Steven Waggoner will be joining Cytocore's medical advisory board.

Michael Gilman, Ph.D. has been appointed to Epix Pharmaceuticals' board of directors.

PDL BioPharma has elected Bradford S. Goodwin as a member of its board of directors.

Alder Biopharmaceuticals has named Clay B. Siegall, Ph.D., to its board of directors.

Celgene has elected Rodman L. Drake to its board of directors.